Skip to main content
Account

Peer review reports

From: Lomustine with or without reirradiation for first progression of glioblastoma, LEGATO, EORTC-2227-BTG: study protocol for a randomized phase III study

Original Submission
2 May 2024 Submitted Original manuscript
23 May 2024 Reviewed Reviewer Report - Kirsty Loudon
30 May 2024 Author responded Author comments - Matthias Preusser
Resubmission - Version 2
30 May 2024 Submitted Manuscript version 2
Publishing
30 May 2024 Editorially accepted
7 Jun 2024 Article published 10.1186/s13063-024-08213-7

Learn about peer review

Back to article page

Navigation